Spastic paraplegia-glaucoma-intellectual disability syndrome

Spastic paraplegia-glaucoma-intellectual disability syndrome (also known as Spastic paraplegia-glaucoma-mental retardation syndrome) is an extremely rare genetic disorder characterized by the combination of progressive spastic paraplegia, congenital or early-onset glaucoma, and intellectual disability. This condition was originally described in a small number of families and remains very rarely reported in the medical literature. The syndrome primarily affects the nervous system, the eyes, and cognitive development. Spastic paraplegia refers to progressive stiffness and weakness of the lower limbs due to dysfunction of the upper motor neurons in the corticospinal tracts of the spinal cord, leading to difficulty with walking and mobility. Glaucoma, which involves increased intraocular pressure and potential damage to the optic nerve, can lead to progressive vision loss if untreated. Intellectual disability ranges from mild to moderate and is typically apparent from early childhood. Additional neurological features may include hyperreflexia and extensor plantar responses. There is currently no cure or disease-specific treatment for this syndrome. Management is supportive and multidisciplinary, involving physiotherapy and antispasticity medications for the spastic paraplegia, ophthalmological treatment (including medications or surgery) to manage glaucoma and preserve vision, and educational and developmental support services for intellectual disability. Regular monitoring by neurology and ophthalmology specialists is recommended.

Common questions about Spastic paraplegia-glaucoma-intellectual disability syndrome